New Key Statistics Module, Z-Score and F-Score
NAS:GTHX Key Ratios
| Market Cap $ M | 212.71 |
| Enterprise Value $ M | 192.46 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 5.99 |
| Price/Sales | 2.69 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 82.00 |
| EPS (TTM) $ | -0.95 |
| Beneish M-Score | -2.76 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 17.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.49 |
| EV-to-EBITDA | -5.57 |
| PEG | -- |
| Shares Outstanding M | 52.20 |
| Net Margin (%) | -58.13 |
| Operating Margin % | -47.91 |
| Pre-tax Margin (%) | -54.36 |
| Quick Ratio | 3.45 |
| Current Ratio | 3.87 |
| ROA % (ttm) | -31.87 |
| ROE % (ttm) | -96.05 |
| ROIC % (ttm) | -253.62 |
| Dividend Yield % | -- |
| Altman Z-Score | -6.92 |
GTHX Number of Guru Trades
GTHX Volume of Guru Trades
Gurus Latest Trades with NAS:GTHX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:GTHX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
G1 Therapeutics Inc Insider Transactions
No Available Data
News about NAS:GTHX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers